Two things that qualify this result.
About SN111 Claims
Claims 111@DeSciClaimsTwo things that qualify this result. 1) The sponsor designed, supported and oversaw the trial. Several of the authors were its employees and some hold shares. The trial data are not public, and access is at the sponsor's discretion. 2) The drug is not available to anyone, and the company behind it has indicated it is not taking this intravenous version forward.
SN111 Claims at a glance
SN111, Claims (α token Ё), is one of the independent markets on the Bittensor network, each with its own α token and its own price. Its α currently trades at 0.003982 τ (≈ $1.03), against 5,413 τ of pool liquidity. On-chain, the best-delegated validator on it yields about 34.92% APR (simple) and 41.79% APY (compounded), emissions add 0.000242 τ to the pool each block, epochs run every 360 blocks. It was registered at block #5,615,562.
Taosis newsletters
Taosis News: the week’s articles from the subnet teams, the press and community newsletters, every Friday. Taosis Weekly: the week’s movers, best yields and chain events, with dollar values, every Monday. Past issues
More from SN111 Claims
Taosis indexes announcements, articles, posts and releases about Bittensor subnets from their own channels and keeps a record of each. The text above is the source’s; the figures are read from the chain by Taosis.